National Sarcoma Audit: Assessing UK Compliance with Cancer Guidelines
Conducted by North Bristol NHS Trust, the National Sarcoma Audit aims to evaluate compliance with sarcoma referral guidelines in the UK. Data collection includes patient demographics, symptoms, healthcare consultations, biopsy details, and more. Results will inform improvements in sarcoma care nationally, with findings to be published in a peer-reviewed journal.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
Giulia Colavitti, Michael Rice, Olivia Smith, Christine Millman, Becky Peach, Thomas Chapman, Thomas Wright, Rachel Clancy Audit Number: CA 78835 North Bristol NHS Trust
Introduction National Audit Assess National Compliance with current guidelines Data to be used by steering bodies to improve services (British Sarcoma Group; British Orthopaedic oncology Society; Bone Cancer Research Trust; Sarcoma UK; (UK) Sarcoma Advisory Group)
Aims To assess compliance with BSG, NICE & Scottish referral guidelines for suspected cancer in the UK for pelvic & appendicular sarcomas.
Methods The Trust will collect data prospectively Data recording: locked, coded Excel spreadsheet. Data collection period from 5thSeptember 2022 to 27thNovember 2022 (inclusive). Submission by 23rdDecember 2022 Inclusion: All patients with a diagnosis of bone and soft-tissue sarcoma
Data collection points: 1) Patient Code 2) Patient Postcode 3) Patient age and sex, tumour location, diagnosis, stage 4) Symptoms at onset and date of first symptom(s) 5) Initial HCP seen 6) Further HCP consultations 7) What was the time from initial presentation to presentation to a sarcoma centre? 8) Biopsy performed elsewhere?
Results Drawn Nationally and discussed before promoting change to enhance care Following implementation of change, reaudit undertaken to assess compliance. Findings pooled and published in peer review journal as part of National findings
